Arch Therapeutics Inc (ARTH)

[Regis999]

Soooo True. Arch needs institutional ownership to get to the next level. Dr. Norchi who I like you have met is tailored to go after the institutions.

The CEO is a MD, MIT MBA and Former Portfolio Manager at Putnam $4 Billion Healthcare Fund.

CEO Dr. Norchi: "I teach diversification but have ALL my eggs are in Arch."

Elevator Summary of ARCH http://www.archtherapeutics.blogspot.com/





The Company’s product, AC5, a liquid peptide, should result in faster, safer, simpler surgery with substantial savings in time of surgery (some have estimated potentially up to 60%).



Anytime a hole in the body occurs one needs to worry about bleeding, leaking and contamination to mitigate infection. Arch’s AC5 to address these needs. Arch intends to transform the landscape of interventional healthcare with products to seal and protect leaking and bleeding tissue.